Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Approved save search
Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors
Published: 2024-04-23 (Crawled : 18:00) - globenewswire.com
NVS | News | $97.295 2.29% 0.0% 3.7M
|
Health Technology
|
| O: 4.32%
H: 0.0%
C: 0.0%
lutathera fda first approved tumors for novartis therapy
CARVYKTI® (ciltacabtagene autoleucel) Approved by the European Commission for Second-line Treatment of Patients with Relapsed and Refractory Multiple Myeloma
Published: 2024-04-22 (Crawled : 18:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.29%
H: 0.0%
C: 0.0%
LEGN | News | $47.42 0.77% 0.76% 1.8M
|
Health Technology
|
| O: 0.39%
H: 1.73%
C: 1.49%
carvykti approved treatment for
CARFAX Car Listings Approved for GM's IMR Turnkey Program
Published: 2024-04-22 (Crawled : 17:00) - prnewswire.com
SPGI | News | $413.275 -0.88% 0.0% 2.1M
|
Commercial Services
|
| O: 0.59%
H: 0.7%
C: 0.47%
approved for program
Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)
Published: 2024-04-19 (Crawled : 10:00) - globenewswire.com
ALVO | $13.39 0.45% 0.45% 200K
|
n/a
|
| O: 1.16%
H: 7.28%
C: 1.3%
KMDA | $5.1 -0.99% 5.3K
|
Health Technology
|
| O: 1.76%
H: 0.0%
C: 0.0%
humira biosimilar approved for agreement
Molecular Partners Announces All Board Proposals Approved at the Annual General Meeting
Published: 2024-04-17 (Crawled : 15:00) - globenewswire.com
MOLN | $3.88 -3.54% 520
|
Professional, Scientific, and T...
|
| O: -4.09%
H: 1.33%
C: 1.33%
approved meeting molecular
Illumina's planned divestment of GRAIL approved by the European Commission
Published: 2024-04-12 (Crawled : 13:00) - prnewswire.com
ILMN | $124.41 3.46% 3.34% 1.3M
|
Health Technology
|
| O: -1.3%
H: 4.53%
C: -1.5%
approved
FASENRA approved for treatment of children aged 6 to 11 with severe asthma
Published: 2024-04-11 (Crawled : 12:00) - biospace.com/
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: 1.47%
H: 1.16%
C: -1.27%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: 3.34%
H: 0.27%
C: -0.62%
children approved treatment for
C4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor
Published: 2024-04-08 (Crawled : 14:00) - biospace.com/
CCCC | $6.89 0.44% 0.44% 910K
|
Health Technology
|
| O: -1.57%
H: 0.0%
C: 0.0%
cft1946 approved preclinical for therapeutics
Astrotech Announces Listing to the GSA as an Approved United States Government Vendor
Published: 2024-04-08 (Crawled : 13:00) - globenewswire.com
ASTC | $9.261 2.41% 700
|
Electronic Technology
|
| O: 0.1%
H: 6.9%
C: 6.9%
approved
C4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor Standard of Care Combinations at the American Association for Cancer Research Annual Meeting 2024
Published: 2024-04-08 (Crawled : 12:00) - globenewswire.com
CCCC | $6.89 0.44% 0.44% 910K
|
Health Technology
|
| O: -1.57%
H: 0.0%
C: 0.0%
cft1946 association approved cancer care research preclinical for meeting therapeutics
CARVYKTI® is the First and Only BCMA-Targeted Treatment Approved by the U.S. FDA for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received at Least One Prior Line of Therapy
Published: 2024-04-06 (Crawled : 04:20) - prnewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
| Email alert
Add to watchlist
carvykti fda first approved one treatment for therapy
New solar projects approved for Dominion Energy Virginia customers
Published: 2024-04-01 (Crawled : 14:00) - prnewswire.com
ENB 3 d | $35.42 0.2% 0.0% 12M
|
Industrial Services
|
| O: 0.06%
H: 0.0%
C: -1.02%
D | $50.67 0.08% 0.0% 4.6M
|
Utilities
|
| O: -0.16%
H: 0.26%
C: 0.1%
energy approved solar
Vafseo® approved by the U.S. FDA for the treatment of anemia due to chronic kidney disease in dialysis-dependent adult patients
Published: 2024-03-28 (Crawled : 07:00) - prnewswire.com
TVTX | $5.745 -1.8% -1.83% 1.2M
|
Health Technology
|
| O: 0.91%
H: 3.1%
C: -0.39%
AKBA | $1.365 0.37% 0.37% 2.1M
|
Health Technology
|
| O: 10.27%
H: 0.4%
C: -25.91%
vafseo fda disease kidney anemia approved treatment
Astellas' VYLOY™ (zolbetuximab) Approved in Japan for Treatment of Gastric Cancer
Published: 2024-03-26 (Crawled : 12:00) - prnewswire.com
ALPMY | News | $9.53 -1.11% 690K
|
Manufacturing
|
| O: -1.65%
H: 3.36%
C: 3.17%
japan approved cancer treatment
Regeneron Hit With Two CRLs, J&J’s PAH Treatment Approved
Published: 2024-03-25 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
PRGO | $30.5 1.46% 0.0% 1.1M
|
Health Technology
|
| O: 0.35%
H: 0.35%
C: -1.34%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: 0.0%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: 0.0%
approved treatment
Aemetis Approved by USCIS for $200 million of EB-5 Investment in Biogas, SAF and Carbon Sequestration Projects
Published: 2024-03-21 (Crawled : 12:00) - globenewswire.com
AMTX | $3.89 7.31% 6.81% 1.2M
|
Process Industries
|
| O: 18.36%
H: 21.06%
C: 18.06%
approved million
Orchard Therapeutics Outlines U.S. Launch Plans for Lenmeldy™ (atidarsagene autotemcel), the Only Approved Therapy for Children with Early-onset Metachromatic Leukodystrophy
Published: 2024-03-20 (Crawled : 11:00) - globenewswire.com
ORTX | $16.7 0.0% 370K
|
Health Technology
| Email alert
Add to watchlist
children approved therapeutics therapy
Ferinject® approved by Health Canada for the treatment of iron deficiency anemia in adult and pediatric patients and iron deficiency in adult patients with heart failure
Published: 2024-03-19 (Crawled : 11:00) - prnewswire.com
TVTX | $5.745 -1.8% -1.83% 1.2M
|
Health Technology
|
| O: -0.7%
H: 5.47%
C: 4.91%
ferinject health anemia approved treatment canada heart
Canoo’s Oklahoma City Manufacturing Facility Approved as Foreign Trade Zone
Published: 2024-03-18 (Crawled : 10:00) - globenewswire.com
GOEV A | $3.16 -7.06% -7.59% 3.5M
|
|
| O: 20.62%
H: 65.81%
C: 23.93%
approved city zone
XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps
Published: 2024-03-15 (Crawled : 20:00) - globenewswire.com
OPTN | $0.9709 -5.74% -6.09% 670K
|
Health Services
| Email alert
Add to watchlist
fda first xhance approved treatment
Gainers vs Losers
| 79% | 21% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 870K
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.